Status:
WITHDRAWN
Efficacy of Topical 95% TCA in the Treatment of CIN 1 or Less After Low-grade Abnormality of Screening Test
Lead Sponsor:
Department of Medical Services Ministry of Public Health of Thailand
Conditions:
CIN1
Trichloroacetic Acid
Eligibility:
FEMALE
18-70 years
Phase:
PHASE2
PHASE3
Brief Summary
To evaluate the efficacy of topical 95% TCA in the treatment of CIN 1 or less after low grade abnormality of screening test
Detailed Description
The patients meeting inclusion criteria were initially divided into two groups which are no lesion and having lesion at cervix on colposcopic examination. Participant in no lesion group were divided ...
Eligibility Criteria
Inclusion
- Women who have low-grade abnormality result such as ASC-US, LSIL, HPV 16/18 positive, persistent HPV infection after cervical cancer screening test
- No history of endometrial or cervical cancer
- Pregnancy test negative
- Good communication in Thai language
- Vouluntarily participate to the study
Exclusion
- Pregnancy test positive after participate in the study
- Pathologic result from colposcopic biopsy (before intervention) is high-grade abnormality such as HSIL, CIN2-3 or AIS
Key Trial Info
Start Date :
November 30 2023
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 1 2023
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT06188104
Start Date
November 30 2023
End Date
December 1 2023
Last Update
January 3 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Rajavithi hospital
Phaya Thai, Bangkok, Thailand, 10400